Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
House Ethics drops cases against four members

House Ethics drops cases against 4 members

In a final burst of horse trading for the 118th Congress, the House Ethics Committee announced that it was ending campaign finance-related investigations into Reps. Sanford Bishop (D-Ga.), Wesley Hunt (R-Texas), Ronny Jackson (R-Texas) and Alex Mooney (R-W.Va.).

But the Ethics panel also released a statement cautioning members against the personal use of campaign funds. And it issued new guidance spelling out what’s allowable — and perhaps more importantly, what’s not.

Here’s the key portion from the Ethics Committee’s statement:

In a 2020 referral to the Ethics Committee, the Office of Congressional Ethics — the independent ethics watchdog — found that there was “substantial reason to believe” that Bishop “converted campaign funds from Sanford Bishop for Congress to personal use, or Rep. Bishop’s campaign committee expended funds that were not attributable to bona fide campaign or political purposes.” Bishop’s office said the veteran lawmaker implemented new campaign reporting practices and personally paid back some expenses.

OCE also alleged Hunt and Jackson improperly used campaign funds to pay for a private club. Both lawmakers denied that they’d committed any ethics violations.

In 2021, OCE alleged that Mooney improperly received a trip to Aruba from a campaign vendor, as well as using official staff for campaign work and “personal errands.”

OCE also asserted Mooney “may have withheld, concealed, or otherwise falsified information during an OCE investigation.”

Mooney, who is retiring after losing a GOP primary to now Sen.-elect Jim Justice (R-W.Va.), insisted he had done nothing wrong and blamed Democrats for the probe.

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.